Examiner: KRINOS, EMILY LYNN

Tech Center 1600 • Art Units: 1614 1615

This examiner grants 0% of resolved cases

Performance Statistics

—

Allow Rate

-60.0% vs TC avg

Total Applications

—

Interview Lift

Avg Prosecution Days

Based on 0 resolved cases, 2023–2026

§101 Eligibility

20.0%

§102 Novelty

80.0%

§103 Obviousness

§112 Clarity

App #	Title	Status	Assignee
19100776	COMPOSITIONS FOR THE TREATMENT OF CFTR-MEDIATED DISEASES	Non-Final OA	Vertex Pharmaceuticals Incorporated
18817316	PERSONAL CARE COMPOSITION WITH N-CAPRYLOYL L-GLUTAMINE AND GLYCERYL MONOUNDECYLENATE AS PRESERVATIVE	Non-Final OA	GALAXY SURFACTANTS LTD.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.